Premature birth associated with a favorable course in gestational alloimmune liver disease (GALD): A case report
- PMID: 37009281
- PMCID: PMC10054034
- DOI: 10.3389/fped.2023.1104530
Premature birth associated with a favorable course in gestational alloimmune liver disease (GALD): A case report
Abstract
Gestational alloimmune liver disease (GALD) is a rare neonatal disorder with high mortality and morbidity. The patients come to caregivers' attention aged a few hours or days. The disease manifests as acute liver failure with or without siderosis. The differential diagnosis of neonatal acute liver failure (NALF) is broad, including mainly immunologic, infectious, metabolic and toxic disorders. The most common cause, however, is GALD followed by herpes simplex virus (HSV) infection. The best suited pathophysiological paradigm of GALD is that of a maternofetal alloimmune disorder. State of the art treatment combines intravenously administered immunoglobulin (IVIG) with exchange transfusion (ET). We report an infant born at 35 + 2 weeks' gestation in whom GALD had a favorable course, of interest because premature birth in our patient may have exerted protective aspects and lessened morbidity in that intrauterine exposure to maternal complement-fixing antibodies was shortened. The diagnosis of GALD was challenging and difficult. We suggest a modified diagnostic algorithm combining clinical findings with histopathologic findings in liver and lip mucosa and, if available, on abdominal magnetic resonance imaging-study focusing on the liver, spleen, and pancreas. This diagnostic workup must be followed by ET and subsequent administration of IVIG without delay.
Keywords: gestational alloimmune liver disease; liver disease; neonatal acute liver failure; neonatal hemochromatosis; prematurit; prematurity.
© 2023 Mulzer, Reutter, Jüngert, Knisely, Schmid, Hoerning and Morhart.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Neonatal hemochromatosis.J Clin Exp Hepatol. 2013 Dec;3(4):313-20. doi: 10.1016/j.jceh.2013.10.004. Epub 2013 Nov 27. J Clin Exp Hepatol. 2013. PMID: 25755519 Free PMC article. Review.
-
Gestational alloimmune liver disease treated with exchange transfusion and intravenous immunoglobulin: A case study.Transfus Apher Sci. 2022 Jun;61(3):103347. doi: 10.1016/j.transci.2021.103347. Epub 2021 Dec 22. Transfus Apher Sci. 2022. PMID: 35034842
-
The Effect of Prolonged Antenatal Intravenous Immunoglobulin Treatment in Preventing Gestational Alloimmune Liver Disease-A Case Series with Literature Review.AJP Rep. 2025 Jan 7;15(1):e1-e5. doi: 10.1055/a-2496-8690. eCollection 2025 Jan. AJP Rep. 2025. PMID: 39780941 Free PMC article.
-
Liver Failure and Conjugated Hyperbilirubinemia in a Preterm Neonate: Role of Early IVIG and Exchange Transfusion.AJP Rep. 2018 Apr;8(2):e95-e98. doi: 10.1055/s-0038-1649339. Epub 2018 May 14. AJP Rep. 2018. PMID: 29765787 Free PMC article.
-
Magnetic resonance imaging of neonatal hemochromatosis.Pediatr Radiol. 2022 Feb;52(2):334-339. doi: 10.1007/s00247-021-05008-9. Epub 2021 Mar 12. Pediatr Radiol. 2022. PMID: 33710405 Review.
References
Publication types
LinkOut - more resources
Full Text Sources